Company intelligence / Profile preview

SaponiQx

Lexington, Massachusetts, United Statessaponiqx.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

SaponiQx has commercialized the proprietary saponin-based adjuvant STIMULON™ QS‑21, which forms a key component of the AS01 adjuvant used in several leading vaccines such as GSK’s Shingrix. The company’s cell culture–based manufacturing process enables scalable and sustainable production compared to traditional extraction from Chilean tree bark. Clinical results for products using their technology include high efficacy rates in approved vaccines like Shingrix. Next-generation programs are at discovery or preclinical stages.

Therapeutic areas
Infectious Diseases
Modalities
Vaccine adjuvant (Saponin-based)Biologic (adjuvants are biologically derived)Small molecule (saponins are small molecules by structure)
Industry
Biotech
02

Drug pipeline

2 assets

QS-X

Preclinical

1 more asset in the full pipeline.

Request access →
03

Partnerships

Ginkgo Bioworks – strategic partnership on cell programming and metabolic engineering for novel/adaptive manufacturing processes and new vaccine/adjutant discoveryProbius – collaboration on quantum molecular spectroscopy–driven AI design of new saponinsU.S. Department of Defense DTRA funding support.

Beyond the preview

Go deeper on SaponiQx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SaponiQx.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call